Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle atm atr'

Search results for: 'research area cell cycle atm atr'

Items 1-10 of 11

Page
per page
  1. SB1317
    A3794 SB1317
    Summary: CDK,JAK and FLT inhibitor
      insoluble in H2O; ≥44.87 mg/mL
  2. WP1066
    A4140 WP1066
    Target: STAT|JAK
    Summary: JAK2/STAT3 inhibitor,cell-permeable
      insoluble in H2O; ≥17.8 mg/mL
  3. AZD1480
    A4137 AZD1480
    Target: JAK
    Summary: JAK2 inhibitor,ATP-competitive and novel
      insoluble in H2O; ≥93.8 mg/mL
  4. TG101209
    A4145 TG101209
    Summary: JAK2/3 inhibitor
      ≥25.5 mg/mL
  5. SD 1008
    A4515 SD 1008
    Summary: Inhibitor of JAK2/STAT3 signaling pathway,apoptosis inducer
      <32.94 mg/mL
  6. JAK2 Inhibitor V, Z3
    A3514 JAK2 Inhibitor V, Z3
    Summary: Jak2 tyrosine kinase inhibitor
      Soluble in DMSO or ethanol
  7. Cercosporamide
    A4511 Cercosporamide
    Target: JAK|MNK
    Summary: Mnk2 and JAK3 inhibitor
      soluble in DMSO
  8. Lestaurtinib
    A4513 Lestaurtinib
     1 Citation
    Summary: JAK2/FLT3/TrkA inhibitor
      Soluble in DMSO
  9. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  10. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL

Items 1-10 of 11

Page
per page